Oct 12 (Reuters) - Spark Therapeutics Inc's experimental gene therapy for a rare form of blindness improves vision and should be approved, advisers to the Food and Drug Administration concluded on Thursday, paving the way for the first U.S. gene therapy for an inherited disease.


00


Reuters

Latest News

USA Today: 49ers make QB change; Cowboys get to keep Elliott active

USA Today: Gamecocks' rise, Lady Vols' fall reflect SEC's major changes

USA Today: A long road back to F1 for New Zealand's Brendon Hartley

USA Today: Redskins put rookie defensive lineman Jonathan Allen on IR

USA Today: Vandy coach: Lack of White House invite a 'slap in the face'

USA Today: Dale Jr.'s team posts baby celebration video

Wall Street Journal: 'Historical Fiction' at Duke

Wall Street Journal: Japan's Hopeful Election

Daily Mail: Defying Trump, EU leaders commit to Iran nuclear accord

Daily Mail: Business Highlights

Daily Mail: The flying insects the planet depends on plummets by 75%

Daily Mail: Everton star Ashley Williams tries to play down Lyon brawl

Daily Mail: Harvey Weinstein being investigated for RAPE in LA

CTV News: Calgary man accused in botched barbed wire hoax skips court date

CTV News: Puerto Rico still stumbles in the dark a month after Hurricane Maria

Reuters: California Dept of Insurance estimates wildfires losses at $1.05 billion

WashingtonPost: Cam Newton skips mandatory news conference with no explanation

FOX: Police seized washer, dryer and other items from missing Texas girl's home

FOX: Chlorine leak at preschool's pool sends children to hospital

FOX: Gas station clerk faces murder charges for allegedly shooting man accused of stealing $1 candy bag

FOX: Gas station clerk faces murder charges for allegedly shooting man accused of stealing $1 candy bag

USA Today: Snapchat is selling a dancing hot dog costume

Daily Mail: Los Angeles police open Weinstein sex assault investigation